Table 10 Results on the Camelyon+ dataset with Gigapath-extracted features.

From: Comprehensive Benchmark Dataset for Pathological Lymph Node Metastasis in Breast Cancer Sections

Methods

Acc (%)

AUC (%)

F1 (%)

Recall (%)

Precision (%)

Kappa

Gigapath5 (WSIs pre-trained)

Max-MIL

81.4 ± 6.62

86.6 ± 6.96

55.4 ± 5.93

54.6 ± 5.35

54.9 ± 5.53

0.65 ± 0.11

Mean-MIL

77.4 ± 3.20

79.1 ± 3.17

46.3 ± 4.24

46.3 ± 4.61

53.6 ± 9.24

0.53 ± 0.09

ABMIL19

79.2 ± 2.43

92.1 ± 0.27

65.7 ± 6.11

58.1 ± 5.31

58.6 ± 0.99

0.68 ± 0.03

Gate-ABMIL19

84.9 ± 3.00

89.7 ± 3.41

59.6 ± 1.61

58.7 ± 2.70

59.5 ± 4.52

0.69 ± 0.04

CLAM-SB25

85.4 ± 2.93

91.2 ± 2.47

60.8 ± 3.78

59.8 ± 3.56

63.7 ± 8.90

0.72 ± 0.03

CLAM-MB25

86.7 ± 3.01

92.1 ± 2.88

69.1 ± 8.13

66.7 ± 5.36

67.0 ± 3.40

0.70 ± 0.07

DSMIL34

86.5 ± 3.12

89.7 ± 4.70

62.1 ± 4.48

62.3 ± 2.86

64.2 ± 2.46

0.68 ± 0.06

TransMIL24

88.2 ± 2.77

92.8 ± 2.44

67.4 ± 3.54

66.9 ± 2.68

75.5 ± 11.95

0.73 ± 0.07

DTFD35

83.7 ± 2.33

89.4 ± 4.64

59.4 ± 3.78

58.0 ± 4.24

61.3 ± 3.57

0.68 ± 0.07

AMD-MIL33

87.3 ± 1.92

92.6 ± 3.11

65.8 ± 4.68

64.6 ± 4.28

64.6 ± 4.42

0.72 ± 0.05

WiKG36

85.0 ± 3.89

91.3 ± 2.93

59.5 ± 5.13

59.4 ± 6.88

68.0 ± 16.12

0.72 ± 0.06

FR-MIL37

86.2 ± 2.01

90.7 ± 3.11

63.2 ± 3.54

63.8 ± 2.40

75.7 ± 10.20

0.71 ± 0.06